ONVO READ THE FULL ONVO RESEARCH REPORT Organovo Holdings (NASDAQ:ONVO) is a biotechnology company that is both a developer of 3D tissue technology that has the potential to change the way treatments ...

Organovo Holdings (NASDAQ:ONVO) just reported results for the fourth quarter of 2024. Organovo Holdings reported earnings per share of -29 cents. This was above the analyst estimate for EPS of -42 ...

The stock’s fifty day moving average price is $0.49 and its two-hundred day moving average price is $0.69. Organovo has a 52-week low of $0.40 and a 52-week high of $2.05. Get Organovo alerts: ...

SAN DIEGO (AP) — SAN DIEGO (AP) — Organovo Holdings Inc. (ONVO) on Friday reported a loss of $2.5 million in its fiscal second quarter. The San Diego-based company said it had a loss of 14 cents per ...

Organovo Holdings, Inc. is engaged in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary ...

Roth Capital Partners is managing the offering. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on ...

NASDAQ:ONVO opened at $0.45 on Thursday. Organovo has a 12 month low of $0.43 and a 12 month high of $2.05. The firm has a market cap of $6.87 million, a price-to-earnings ratio of -0.32 and a ...

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...

S&P 500 funds are inexpensive and share many similarities, but you'll find small differences in cost and how closely they track their benchmark.

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...